Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Gozal, Yair M ^a   Seyfried, Nicholas T ^a   Gearing, Marla ^a   Glass, Jonathan D ^a   Heilman, Craig J ^a   Wuu, Joanne ^a   Duong, Duc M ^a   Cheng, Dongmei ^a   Xia, Qiangwei ^a   Rees, Howard D ^a   Fritz, Jason J ^a   Cooper, Deborah S ^a   Peng, Junmin ^a   Levey, Allan I ^a   Lah, James J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aggregates; dementia; mass spectrometry; Neurodegeneration; proteomics; ubiquitin

Indexed keywords

2,4 DIENOYL COENZYME A REDUCTASE 2; ALPHA CATENIN; AQUAPORIN 4; CYTOSKELETON PROTEIN; DETERGENT; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; SEPTIN; SEPTIN 11; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TAR DNA BINDING PROTEIN; TRANSKETOLASE; UBIQUITIN; UNCLASSIFIED DRUG; SEPT11 PROTEIN, HUMAN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; GLIA; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; UBIQUITINATION; ADULT; AGED; ANIMAL; CELL STRAIN HEK293; CHEMISTRY; GENETICS; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DETERGENTS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HEK293 CELLS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; SEPTINS;

EID: 82255170813     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-82     Document Type: Article

References (49)

1. Frontotemporal dementia. Neary D, Snowden J, Mann D, Lancet Neurol 2005 4 771 780 10.1016/S1474-4422(05)70223-4 16239184 (Pubitemid 41457293)
2. Classification and description of frontotemporal dementias. Neary D, Snowden JS, Mann DM, Ann N Y Acad Sci 2000 920 46 51 11193176 (Pubitemid 32056551)
3. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Okamoto K, Hirai S, Yamazaki T, Sun XY, Nakazato Y, Neurosci Lett 1991 129 233 236 10.1016/0304-3940(91)90469-A 1660578
4. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M, Nature 2006 442 916 919 10.1038/nature05016 16862116 (Pubitemid 44285946)
5. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C, Nature 2006 442 920 924 10.1038/nature05017 16862115 (Pubitemid 44285947)
6. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM, Science 2006 314 130 133 10.1126/science.1134108 17023659 (Pubitemid 44547757)
7. TDP-43 A315T mutation in familial motor neuron disease. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ, Ann Neurol 2008 63 535 538 10.1002/ana.21344 18288693 (Pubitemid 351614720)
8. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE, Science 2008 319 1668 1672 10.1126/science.1154584 18309045 (Pubitemid 351432505)
9. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA, Nat Genet 2008 40 572 574 10.1038/ng.132 18372902 (Pubitemid 351601218)
10. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve B, Graff-Radford NR, Wszolek ZK, Caselli RJ, Dickson DW, Mackenzie IR, Petrucelli L, Rademakers R, PLoS Genet 2008 4 1000193 10.1371/journal.pgen.1000193 18802454
11. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering-Brown S, Dickson D, Petrucelli L, J Neurosci 2007 27 10530 10534 10.1523/JNEUROSCI.3421-07.2007 17898224 (Pubitemid 47501990)
12. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Johnson BS, McCaffery JM, Lindquist S, Gitler AD, Proc Natl Acad Sci USA 2008 105 6439 6444 10.1073/pnas.0802082105 18434538 (Pubitemid 351758364)
13. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW, Nat Neurosci 2011 14 459 468 10.1038/nn.2779 21358643
14. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. Geser F, Martinez-Lage M, Kwong LK, Lee VM, Trojanowski JQ, J Neurol 2009
15. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Lagier-Tourenne C, Polymenidou M, Cleveland DW, Hum Mol Genet 2010 19 46 64 10.1093/hmg/ddq137 20400460
16. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, Bruce J, Grossman M, Trojanowski JQ, Lee VM, Am J Pathol 2006 169 1343 1352 10.2353/ajpath.2006.060438 17003490 (Pubitemid 351194368)
17. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DM, Acta Neuropathol 2006 112 539 549 10.1007/s00401-006-0138-9 17021754 (Pubitemid 44550678)
18. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM, Acta Neuropathol 2007 114 5 22 10.1007/s00401-007-0237-2 17579875 (Pubitemid 47029055)
19. A new subtype of frontotemporal lobar degeneration with FUS pathology. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR, Brain 2009 132 2922 2931 10.1093/brain/awp214 19674978
20. Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Ishihama Y, Sato T, Tabata T, Miyamoto N, Sagane K, Nagasu T, Oda Y, Nat Biotechnol 2005 23 617 621 10.1038/nbt1086 15834404 (Pubitemid 41724902)
21. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM, Xu P, Wijayawardana SR, Hanfelt J, Nakagawa T, Sheng M, Peng J, Mol Cell Proteomics 2006 5 1158 1170 10.1074/mcp.D500009-MCP200 16507876 (Pubitemid 43985938)
22. Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11. Nagata K, Asano T, Nozawa Y, Inagaki M, J Biol Chem 2004 279 55895 55904 10.1074/jbc.M406153200 15485874 (Pubitemid 40066597)
23. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt JJ, Funderburk C, Peng J, Lah JJ, Levey AI, J Proteome Res 2009 8 5069 5079 10.1021/pr900474t 19746990
24. Genetic control of the cell division cycle in yeast. IV. Genes controlling bud emergence and cytokinesis. Hartwell LH, Exp Cell Res 1971 69 265 276 10.1016/0014-4827(71)90223-0 4950437
25. Here come the septins: novel polymers that coordinate intracellular functions and organization. Spiliotis ET, Nelson WJ, J Cell Sci 2006 119 4 10 10.1242/jcs.02746 16371649 (Pubitemid 43169293)
26. Assembly of mammalian septins. Kinoshita M, J Biochem 2003 134 491 496 10.1093/jb/mvg182 14607974 (Pubitemid 37442871)
27. Expression profiling the human septin gene family. Hall PA, Jung K, Hillan KJ, Russell SE, J Pathol 2005 206 269 278 10.1002/path.1789 15915442 (Pubitemid 40903191)
28. Role of Septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Tada T, Simonetta A, Batterton M, Kinoshita M, Edbauer D, Sheng M, Curr Biol 2007 17 1752 1758 10.1016/j.cub.2007.09.039 17935993 (Pubitemid 47576672)
29. FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Kojima K, Sakai I, Hasegawa A, Niiya H, Azuma T, Matsuo Y, Fujii N, Tanimoto M, Fujita S, Leukemia 2004 18 998 1005 10.1038/sj.leu.2403334 14999297 (Pubitemid 38714626)
30. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW, J Clin Invest 2004 114 121 130 15232619 (Pubitemid 39071651)
31. Septin 11 is present in GABAergic synapses and plays a functional role in the cytoarchitecture of neurons and GABAergic synaptic connectivity. Li X, Serwanski DR, Miralles CP, Nagata K, De Blas AL, J Biol Chem 2009 284 17253 17265 10.1074/jbc.M109.008870 19380581
32. Identification of septins in neurofibrillary tangles in Alzheimer's disease. Kinoshita A, Kinoshita M, Akiyama H, Tomimoto H, Akiguchi I, Kumar S, Noda M, Kimura J, Am J Pathol 1998 153 1551 1560 10.1016/S0002-9440(10)65743-4 9811347 (Pubitemid 28509912)
33. Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies. Ihara M, Tomimoto H, Kitayama H, Morioka Y, Akiguchi I, Shibasaki H, Noda M, Kinoshita M, J Biol Chem 2003 278 24095 24102 10.1074/jbc.M301352200 12695511 (Pubitemid 36830243)
34. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM, Proc Natl Acad Sci USA 2000 97 13354 13359 10.1073/pnas.240347797 11078524
35. A mitotic septin scaffold required for Mammalian chromosome congression and segregation. Spiliotis ET, Kinoshita M, Nelson WJ, Science 2005 307 1781 1785 10.1126/science.1106823 15774761 (Pubitemid 40388620)
36. Biochemical and cell biological characterization of a mammalian septin, Sept11. Hanai N, Nagata K, Kawajiri A, Shiromizu T, Saitoh N, Hasegawa Y, Murakami S, Inagaki M, FEBS Lett 2004 568 83 88 10.1016/j.febslet.2004.05.030 15196925 (Pubitemid 38757960)
37. The cytoskeleton in neurodegenerative diseases. Cairns NJ, Lee VM, Trojanowski JQ, J Pathol 2004 204 438 449 10.1002/path.1650 15495240 (Pubitemid 39468155)
38. Borg/septin interactions and the assembly of mammalian septin heterodimers, trimers, and filaments. Sheffield PJ, Oliver CJ, Kremer BE, Sheng S, Shao Z, Macara IG, J Biol Chem 2003 278 3483 3488 12446710 (Pubitemid 36801265)
39. Protein aggregation and neurodegenerative disease. Ross CA, Poirier MA, Nat Med 2004 10 Suppl 10 17 15272267
40. A "Two-hit" Hypothesis for Inclusion Formation by Carboxyl-terminal Fragments of TDP-43 Protein Linked to RNA Depletion and Impaired Microtubule-dependent Transport. Pesiridis GS, Tripathy K, Tanik S, Trojanowski JQ, Lee VM, J Biol Chem 2011 286 18845 18855 10.1074/jbc.M111.231118 21454607
41. Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome. Gozal YM, Cheng D, Duong DM, Lah JJ, Levey AI, Peng J, Methods Enzymol 2006 412 77 93 17046653 (Pubitemid 44548575)
42. Proteomic analysis of hippocampal dentate granule cells in frontotemporal lobar degeneration: application of laser capture technology. Gozal YM, Dammer EB, Duong DM, Cheng D, Gearing M, Rees HD, Peng J, Lah JJ, Levey AI, Front Neurol 2011 2 24 21577247
43. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Neurology 2005 65 1863 1872 10.1212/01.wnl.0000187889.17253.b1 16237129 (Pubitemid 43970103)
44. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Ince PG, Lowe J, Shaw PJ, Neuropathol Appl Neurobiol 1998 24 104 117 10.1046/j.1365-2990.1998.00108.x 9634206 (Pubitemid 28175040)
45. Neuropathology of Pick's disease. Dickson DW, Neurology 2001 56 16 20 11402145
46. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I, J Neuropathol Exp Neurol 2002 61 935 946 12430710 (Pubitemid 35278715)
47. Preliminary NINDS neuropathologic criteria for Steele-Richardson- Olszewski syndrome (progressive supranuclear palsy). Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I, Neurology 1994 44 2015 2019 7969952 (Pubitemid 24349498)
48. Microarray data analysis: from disarray to consolidation and consensus. Allison DB, Cui X, Page GP, Sabripour M, Nature reviews 2006 7 55 65 10.1038/nrg1749 16369572 (Pubitemid 41828948)
49. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Seyfried NT, Gozal YM, Dammer EB, Xia Q, Duong DM, Cheng D, Lah JJ, Levey AI, Peng J, Mol Cell Proteomics 2010 9 705 718 10.1074/mcp.M800390-MCP200 20047951